Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Psychedelic Drug Trials, Patient Safety Take Spotlight at FDA Hearing

(MedPage Today) -- The FDA gathered public feedback Monday during a 4-hour hearing about potential therapeutic use of psychedelic drugs. Most of the hearing's 80 speakers offered strong support for psychedelic medicine, highlighting its efficacy...

Psychedelic Drug Trials, Patient Safety Take Spotlight at FDA Hearing

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 15 September →